Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares faded 1% to $19.60. The company on Jan. 23 commenced an underwritten public offering of shares of its common stock. Share volume was 2.6 million, rapidly catching up on an all-day average of 2.8 million
